Ting Zhang

发表

Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.

T. Mizuno, K. Takeuchi, A. Hruza, 2017, Bioorganic & medicinal chemistry letters.

Development of a novel tricyclic class of potent and selective FIXa inhibitors.

J. Metzger, R. Berger, Hong Li, 2015, Bioorganic & medicinal chemistry letters.

ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2010, Bioorganic & medicinal chemistry.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.

Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.

Yuan He, Z. Yi, Yihua Chen, 2022, Future medicinal chemistry.

Umami peptides screened based on peptidomics and virtual screening from Ruditapes philippinarum and Mactra veneriformis clams.

D. Pan, Ya-li Dang, Changyu Zhou, 2022, Food chemistry.

Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure-Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program.

Y. Liu, S. Hill, E. Sherer, 2016, Journal of medicinal chemistry.

An overview on natural farnesyltransferase inhibitors for efficient cancer therapy

Gao Hongwei, Yingni Sun, Ting Zhang, 2020, Journal of enzyme inhibition and medicinal chemistry.

CXCR4 inhibition suppresses Cd-induced renal oxidative stress, apoptosis, and fibrosis by inhibiting the TGF-β1/Smad pathway

Yangbiao He, X. Lang, Dong-hui Cheng, 2023, Arabian Journal of Chemistry.

Physicochemical properties, structure and biological activities of a novel low-molecular-weight hawthorn pectin

Haoyu Wang, Yiwei Zhu, Chuanhe Zhu, 2022, Process Biochemistry.

Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer

Kaixian Chen, C. Luo, H. Ding, 2021, Bioorganic & Medicinal Chemistry.

C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

J. Y. Roberge, B. Seed, Huawei Cheng, 2011, Bioorganic & medicinal chemistry letters.

Rapid development of two factor IXa inhibitors from hit to lead.

W. Greenlee, R. Berger, E. Sherer, 2015, Bioorganic & medicinal chemistry letters.

Development of a novel class of potent and selective FIXa inhibitors.

E. Sherer, K. Ellsworth, W. Geissler, 2015, Bioorganic & medicinal chemistry letters.

Novel orthodiphenyl five-member N-heteroaromatic compounds as potent anticancer cell agents

Z. Yi, Yihua Chen, Shijia Hu, 2022, Medicinal Chemistry Research.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.